<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-107526</identifier>
<setSpec>1134-282X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Identification of some characteristics of Primary Health Care physicians that influence pharmaceutical costs</dc:title>
<dc:description xml:lang="en">Objective. Aging and medicalisation are leading to a progressive growth in pharmaceutical expenditure, which is difficult to measure. It is important to develop social studies of this drug spending in order to support the policies of containment. The aim of this study is to identify elements that influence pharmaceutical expenditure of Primary Care physicians in the Health Area of Cuenca (Spain). Material and methods. A retrospective observational study using multilevel models of pharmaceutical expenditures by physicians between 2006 and 2009. It took into account the particular characteristics of each doctor and their patients. Results. The average pharmaceutical expenditure by doctor and patient was &#128; 277.13 year. In addition, a one-point of increase in the rate of referrals to specialised care increases pharmaceutical expenditure by 2.97 &#128; per year and an increase in the percentage of generic drugs prescribed reduced in 2.54 &#128; per year. These two variables and the percentage of retired patients (pensioners) are the most important factors to explain the variability in pharmaceutical expenditure. In contrast, the characteristics of physicians such as education, tenure, seniority, or age does not influence pharmaceutical costs. Conclusions. This study supports the importance of developing interventions in prescription policies. It will be of particular interest to those physicians with higher quotas of elderly patients. It also shows a significant relationship in pharmaceutical expenditures between primary and specialist physicians, which needs to be clarified by future studies(AU)</dc:description>
<dc:creator>Segura-Benito, M. J</dc:creator>
<dc:creator>Moya-Martínez, P</dc:creator>
<dc:creator>Escribano-Sotos, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Envejecimiento y medicalización de la sociedad suponen un crecimiento del gasto farmacéutico. Interesa desarrollar estudios que evalúen este gasto para dar soporte a políticas para su contención. El objetivo del estudio es determinar elementos clave que influyen en el gasto farmacéutico inducido por médicos de atención primaria del Área de Salud de Cuenca. Material y métodos. Se desarrolla un estudio observacional longitudinal retrospectivo mediante modelos multinivel del gasto farmacéutico realizado por médicos entre 2006-2009, teniendo en cuenta características particulares del médico y del cupo de pacientes. Resultados. El gasto farmacéutico medio médico/persona aumenta 2,97 &#128;/año al incrementar un punto la tasa de derivaciones a especializada, reduciéndose 2,54 &#128;/año al incrementar 1% el porcentaje de genéricos prescritos. Estas variables y el porcentaje de pensionistas del cupo, explican la mayor parte de la variabilidad del gasto farmacéutico. Características particulares del médico como edad, formación, plaza en propiedad, antigüedad, no parecen influir significativamente en dicho gasto. Conclusiones. Este trabajo justifica desarrollar intervenciones para fomentar la prescripción por principio activo, fundamentalmente en médicos con alto porcentaje de pensionistas en su cupo. Además, muestra una relación importante entre primaria y especializada en cuanto al gasto farmacéutico sobre la que habría que desarrollar nuevos estudios(AU)</dc:description>
<dc:source>Rev. calid. asist;27(6): 345-350, nov.-dic.2012.</dc:source>
<dc:identifier>ibc-107526</dc:identifier>
<dc:title xml:lang="es">Identificación de algunas características del médico de atención primaria que influyen en el gasto farmacéutico</dc:title>
<dc:subject>^d^s22066</dc:subject>
<dc:subject>^d30152^s22048</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d11756^s22018</dc:subject>
<dc:subject>^d30152^s22066</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31403^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d28630</dc:subject>
<dc:subject>^d16648</dc:subject>
<dc:subject>^d53403^s22066</dc:subject>
<dc:subject>^d53403^s22045</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d30152^s22083</dc:subject>
<dc:subject>^d3380^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201212</dc:date>
</metadata>
</record>
</ibecs-document>
